Show results for
Refine by
Industries served
- Medical / Health Care
- Agriculture
- Monitoring and Testing
- Manufacturing, Other
- Chemical & Pharmaceuticals
- Waste and Recycling
- Water and Wastewater
- Health and Safety
- Government
- Food and Beverage
- Energy
- Retail
- Commercial
- Pulp & Paper
- Real Estate
- Maritime/Shipbuild/Water Transport
- Oil, Gas & Refineries
- Environmental
- Soil and Groundwater
- University / Academia / Research
- Construction & Construction Materials
Disease Development Suppliers Serving Somalia
85 companies found
based inIllkirch-Graffenstaden, FRANCE
Emosis develops and provides physicians with first-in-class, on demand, and user-friendly extended in vitro diagnostic products, centered on lab assay kits to be routinely performed on the rapidly growing new generation of flow cytometers, including ...
based inLondon, UNITED KINGDOM
At Benevolent we build technology in the service of science - to augment human intelligence and inspire the discovery of new medicines for the thousands of diseases that have no treatment. Building the right team is an art not a science. We strive ...
based inHorsholm, DENMARK
At TannerMedico A/S, our aim is to help you sleep comfortable, breathe easier and live healthier. We truly believe that any good treatment aims at killing the cause and not just the symptoms. We are a Scandinavian company with the corporate ...
based inToronto, ONTARIO (CANADA)
20+ Years of Innovation! FUJIFILM VisualSonics designs and manufactures ultra high frequency in vivo imaging systems, for both research and clinical use. FUJIFILM VisualSonics specifically focuses on developing ultrasound technology that has been ...
based inGhent/Zwijnaarde, BELGIUM
Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic ...
based inSint-Denijs Westrem, BELGIUM
We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully ...
Liver disease, a large and growing market globally. Cirrhosis is late-stage liver disease which occurs when scar tissue (fibrosis) replaces healthy tissue. Alcohol and viral hepatitis B and C are common causes of cirrhosis, although there are many ...
based inWoodland, CALIFORNIA (USA)
Hygieia Biological Laboratories is a Woodland, California based biotechnology company engaged in the research, development and manufacturing of innovative veterinary and human vaccines and pharmaceuticals. We have particular expertise in vaccines ...
Preventative health including vaccination is a key focus of good animal management. Hygieia offers inactivated autogenous bacterins and vaccines which are custom manufactured from disease agents specifically found at an individual ranch, zoo, or ...
based inWhitestown, INDIANA (USA)
PTS Diagnostics is an innovative point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company’s name represents the ...
based inUpton-Upon-Severn, UNITED KINGDOM
Established in 1979, Bio-Diagnostics is privately owned, rapidly growing, UK bio-tech business, based 40 miles south west of Birmingham, UK. Bio-Diagnostics is highly regarded and trusted globally, working closely with partners providing, ...
based inSchlieren, SWITZERLAND
InSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide greater confidence in decision making. Our robust and highly physiologically relevant suite of ...
An in vitro PDX model with in vivo-like heterogeneity. 3D InSight™ Tumor Microtissues from Patient-Derived Xenografts (PDX) are custom assay-ready 3D in vitro tumor models engineered to reflect complex tumor biology without the use of ...
based inLondon, UNITED KINGDOM
Founded in 2015, the original idea behind Airfinity was to systematically capture and structure the new science disseminated at conferences, a highly fragmented dataset. However, through working with medical associations and pharma companies, ...
Informational biosecurity strategies, funding allocations and procurement decisions across defence, health and science ministries. Horizon scanning to pre-empt future health emergencies. In collaboration with a number of ministries across the UK, ...
based inGloucestershire, UNITED KINGDOM
Renishaw is a global, high precision metrology and healthcare technology group. We design, develop and deliver solutions and systems that provide unparalleled precision, control and reliability. We are also a world leader in the field of additive ...
Novel chronic and acute catheter systems for direct delivery of therapeutics to the ...
based in, GERMANY
betaSENSE is transforming the landscape of protein diagnostics by focusing on the early detection of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Emerging from pioneering research at Ruhr University Bochum, led by Prof. Dr. Klaus ...
The advancement of the iRS technology from betaSENSE represents a significant innovation in the field of Parkinson's disease diagnostics. This technology addresses the critical unmet medical needs in accurately diagnosing ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
based inSomerset, NEW JERSEY (USA)
Even the most sophisticated, cutting-edge medical diagnostics aren’t of value unless we can get them to those who need them most. At Access Bio, we believe every life is precious, and every human on earth deserves the opportunity to live a healthy ...
based inSeattle, WASHINGTON (USA)
Nexelis is your partner for assay and biomarker development, advanced bioanalytical and laboratory testing, and translational immunology. As the leading specialty laboratory, we have unrivaled expertise in immunology, specifically in the areas of ...
Selecting the appropriate in vivo model for your assays is critical for the success of your preclinical research program. At Nexelis, a Q² Solutions Company, we designed and developed disease specific in vivo ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Pregnenolone-d4-1 is the deuterium labeled Pregnenolone. Pregnenolone (3β-Hydroxy-5-pregnen-20-one) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone acts as a signaling-specific ...
based inSaint-Herblain Cedex, FRANCE
Atlanthera is a drug discovery company focused on bone diseases and bone cancer treatments. The growing medical need and the lack of effective treatments for bone tumors gave rise to Atlanthera in 2011, a drug discovery company focused on bone ...
based inCambridge, UNITED KINGDOM
We’re driven by the shared purpose of breaking new ground in the discovery of new treatments for rare diseases. Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to ...
based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
ACTallo® is a process developed by Immatics for the manufacture of allogeneic, off-the-shelf, TCR-engineered cellular therapies derived from healthy donors’ gamma delta T ...
